Liquid Biopsy Market Trends, Growth and Forecasts Upto 2022

Liquid Biopsy1

The Liquid Biopsy Market Research Report provides forecast and estimates for each application in terms of Market Size, Share, Trend and Growth during the study period (Upto 2022).

View More About this Report :

The report on global liquid biopsy market evaluates the growth trends of the industry through historical study and estimates future prospects based on comprehensive research done by the analysts. The study extensively provides the market share, growth, trends and forecasts for the period 2016–2022. The market size in terms of revenue (USD MN) is calculated for the study period along with the details of the factors affecting the market growth (drivers and restraints).

Download Sample Copy Of this Report :

A. Major Drivers :
– Adoption of liquid biopsies
– Dearth of skilled professionals

B. Major Restraints :
– Help in detection of cancer in its early stage

The comprehensive value chain analysis of the market will assist in attaining better product differentiation, along with detailed understanding of the core competency of each activity involved. The market attractiveness analysis provided in the report aptly measures the potential value of the market providing business strategists with the latest growth opportunities.

C. Major player assessed in the report is :
– Janssen Diagnostics, LLC
– Qiagen
– Rarecells SAS
– Silicon Biosystems
– SRI International
– Myriad Genetics
– Natera Inc
– Personal Genome Diagnostics
– Sysmex Inostics
– Trovagene Inc
– More

The report classifies the market into different segments based on approach of diagnosis, type of cancer application and channel participants. These segments are studied in detail incorporating the market estimates and forecasts at regional and country level. The segment analysis is useful in understanding the growth areas and probable opportunities of the market.

In terms of geography, the Liquid Biopsy market has been segmented into regions such as North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The study provides a detailed view of country-level aspects of the market on the basis of application segments and estimates the market in terms of revenue and volume during the forecast period.


1. By Approach of Diagnosis :

– Circulating Tumor Cells (CTC)
– Circulating Tumor DNA (ctDNA)
– RNA in Exosomes
– Extra-cellular Vesicles (EVs)

2. By Type of Cancer Application :

– Lung Cancer
– Pancreatic Cancer
– Leukemia (Blood Cancer)
– Other Visceral (Deeply Located) Cancers

3. By Channel Participants :

– Cancer Centers and Hospitals
– Contract Research Organizations
– Academic Institutions
– Specialized Research Laboratories

Buy Now this Report :

More Related Reports :

Global Healthcare Cold Chain Market Research Report

Healthcare Cold Chain Service is used for storage and distribution of pharmaceutical products, blood plasma products, tissues and chemicals within the country or across the globe. This process operates on the principle of compressor technology by temperature regulation, ensures a proper shelf life and avoids deterioration of healthcare products.
View More :